Rydoo, the Game-Changing Business Travel and Expense Mobile App That Eliminates Complicated Admin
World leader in Quality of Life services, Sodexo, together with Xpenditure and iAlbatros unveils Rydoo, the new platform that eliminates daily administrative tasks starting with business travel and expense management. Launched in France and worldwide today, Rydoo aims to unlock the full potential of a dynamic yet old-fashioned market, while supporting the digitization of workplaces.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180605006168/en/
A business traveler using Rydoo Travel (Photo: Rydoo)
At work, administrative tasks with no added value are frustrating. We have all spent hours searching for the right flight, queuing at hotel lobbies to check-out and then finally have confusing expense reports to fill in. No salesperson was ever hired to become an expert in travel arrangement or collecting paper receipts. Employees and companies deserve to focus on what matters and what offers value. Rydoo brings this technology to drive efficiency and enable better ways to work.
Now Rydoo reinvents and simplifies travel and expense management to just a few clicks and photos, whilst saving time and optimizing costs.
Game-Changing in Business Travel and Expense Management
Rydoo is the first platform to cover the full scope of any trip or any expense to contribute to a more fulfilling work environment. With an average adoption rate of 93% within the first month, Rydoo proves just how user-friendly it is for employees and efficient it is for companies.
As a result, finance teams in organizations benefit from:
- a 87% reduction in processing cost,
- sources of optimisation thanks to compliance with company policies
- time saving with expense processing time divided by 4
Rydoo is also a SaaS solution that takes just a few days to implement, releasing new features on a weekly basis. Rydoo has a competitive business model, starting at €6 per month/active user.
Rydoo combines a stellar user experience with corporate expectations
Rydoo’s end-to-end platform combines both worlds through two modules to streamline the entire business travel and expense process:
- Rydoo travel helps employees find the right flight, rail ticket or car rental, and book the hotel that suits their needs from among 800 000 accommodation choices, and offers a dashing user experience in less time. Rydoo travel skips the payment phase for employees (no more queuing at the lobby) thanks to central billing - finance teams receive a single invoice gathering all business travel-related information, at the end of the month.
- Rydoo expense allows employees to enjoy the snap-and-process feature that offers automated, paperless expense management while complying with company’s policy. Finance teams easily manage employees’ reimbursements in real-time and control the company’s expense budget.
- Using both modules guarantee full value from this new way of working, but companies can also start with one module, depending on their needs.
Rydoo, CEO, Sébastien Marchon, says : “Rydoo fights with daily life pain points at work by offering an end-user oriented app. Rydoo removes complexity for employees while offering 87% over time productivity for finance teams. By making Rydoo one of the leading players in the travel and expense market, Sodexo aims to improve the quality of life and performance of the organizations it serves.”
Sodexo Mobility & Expense, President, Didier Dumont, adds: “Keeping people efficiently on the move is essential for business success. Rydoo brings the Travel and Expense ecosystem together to gain time and real-time visibility for hassle-free performance. To deliver this to the market in an agile way, we define ourselves as a corp-up that combines the strength of a corporate company and the agility and innovative mindset of a start-up”.
Rydoo reinvents and simplifies business travel and expense management thanks of the expertise its two founding startups it is originated: Xpenditure and iAlbatros. With its 300 enthusiastic employees, Rydoo operates in more than 60 countries; its 6,000 customers (public and private organizations) benefit from the usability and efficiency of its consumer-oriented app. Rydoo is a Sodexo corp-up, the alliance of two startups and a large corporation.
Founded in 1966 by Pierre Bellon in Marseilles, France, Sodexo is the worldwide leader in Quality of Life services, an essential factor in the performance of individuals and organizations. Present in 80 countries, Sodexo delivers to 100 million customers a day a unique array of On-Site Services, Benefits and Rewards Services, and Personal and Home Services. With 50 years' experience covering more than 100 professions, Sodexo offers its clients a comprehensive range of services including hospitality, reception, cleaning, maintenance, technical equipment and facilities maintenance, staff motivation and incentivization, solutions to streamline and optimize personnel relocation and business expenses, as well as home help, daycare, and concierge services. Sodexo's success and performance relies on its independence, its sustainable economic model, and its ability to ensure the development and commitment of its 450,000 employees around the world. Sodexo is represented on the CAC 40 and DJSI indices.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza16.8.2018 05:00 | Pressemelding
BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease, today announced that it has entered into a multi-year research and development (R&D) collaboration with Pfizer Inc. (NYSE: PFE) to develop mRNA-based vaccines for prevention of influenza (flu). Under the terms of the agreement, BioNTech and Pfizer will jointly conduct research and development activities to help advance mRNA-based flu vaccines. Pfizer will assume sole responsibility for further clinical development and commercialization of mRNA-based flu vaccines, following BioNTech’s completion of a first in human clinical study. BioNTech will receive $120 million in upfront, equity and near-term research payments and up to an additional $305 million in potential development, regulatory and commercial milestone payments. In addition, BioNTech will receive up to double-digit tiered royalty payments associated with worldwide sales if the program reac
Maxion Wheels to Showcase Market-Leading Light Weight Commercial Vehicle Wheels at REIFEN 201816.8.2018 04:05 | Pressemelding
Maxion Wheels, the world’s largest producer of wheels, announced today its participation in REIFEN, the leading tire and wheel industry event in Europe, from Sept. 11 – 15, 2018 in Hall 12.1 / Stand D24. For the first time, REIFEN will be co-located with Automechanika Frankfurt at the Messe Frankfurt. “REIFEN is the premier event for European tire and wheel manufacturers and resellers, bringing us together to meet and collaborate on the important aftermarket themes of innovation, service and delivery,” stated Mark Gerardts, Vice President of Global Sales and Marketing, Maxion Wheels. “After a highly popular launch to truck and trailer OEMs in 2017, we’re excited to have the industry’s lightest mass production steel wheel now available to our aftermarket distributors. This wheel, along with several others, including our new 10.00W-20 wide base tubetype and tubeless heavy duty armored vehicles wheel are great examples of our continued efforts to bring our OE multi-application innovations
Lenovo Accelerates Turnaround with Back-to-Back, Double-Digit Quarterly Revenue Growth15.8.2018 23:40 | Pressemelding
Lenovo Group (HKSE: 0992) (PINK SHEETS: LNVGY) today announced results for its first fiscal quarter ended June 30, 2018. For the second straight quarter, Lenovo achieved strong double-digit growth in revenue year-on-year. Group revenue reached US$11.91 billion, up 19% year-on-year. The company also reported strong pre-tax income during the quarter of US$113 million, an improvement of US$182 million year-on-year, as profitability improved across all businesses. In the first fiscal quarter, Lenovo’s profit attributable to equity holders grew to US$77 million, up US$149 million year-over-year. Basic earnings per share in the first fiscal quarter was 0.65 US cents or 5.10 HK cents. “As we persistently execute our 3-wave strategy, all our businesses made solid improvements in both revenue and profitability. Lenovo has passed the turning point and entered a phase of ‘acceleration’ - accelerating the execution of our transformation strategy and accelerating the rising momentum in business per
CORRECTING and REPLACING Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 22:37 | Pressemelding
Please replace the release with the following corrected version due to multiple revisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) The corrected release reads: EBOLA SUCCESSFULLY NEUTRALIZED BY LATEST GENERATION POLYCLONAL IMMUNOTHERAPY Promising new platform can rapidly respond to emerging infectious diseases Sioux Falls, SD, August 15, 2018 – SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted at the Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of He
Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 17:43 | Pressemelding
SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted by the National Interagency Confederation for Biological Research and other collaborators including United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) According to the World Health Organization, Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans with an average fatality rate around 50%.
Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovation15.8.2018 17:05 | Pressemelding
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced it has been honored with a Stevie® Award in the Innovation in Customer Service Management, Planning & Practice category for its ultra-responsive, premium level service in the Asia-Pacific region. This honor marks the Company’s 12th Stevie Award win this year, and the second consecutive year the Company has been recognized by the Asia-Pacific Stevie Awards. Rimini Street recently earned Stevie Awards in several categories, including Company of the Year from the 2018 American Business Awards® and Customer Service Department of the Year from the 2018 Stevie Awards for Sales & Customer Service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005580/en/ Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovat